Original Query: ALL
Previous Study | Return to List | Next Study

Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis (DATA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00926380
Recruitment Status : Active, not recruiting
First Posted : June 23, 2009
Last Update Posted : December 1, 2016
Information provided by (Responsible Party):
Benjamin Leder, MD, Massachusetts General Hospital

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2016

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 8, 2018  

Publications automatically indexed to this study by Identifier (NCT Number):